| Interventional nuclear medicine in the prevention of restenosis following angioplasty. | |
| | |
MedLine Citation:
|
PMID: 12195087 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Restenosis is an unsolved clinical and economic limitation of angioplasty. Local irradiation is a new concept to overcome this problem. The magnitude of this health problem becomes apparent when one recognizes that 166132 percutaneous transluminal coronary angioplasty (PTCA) procedures were performed in Germany in 1999. Each angioplasty has subsequent costs of 6384 DM, which can be reduced to 2161 DM by 50% restenosis reduction due to irradiation [1]. The number of diagnostic and therapeutic procedures is growing by at least 10% per year. |
| | |
Authors:
|
Jörg Kotzerke; H Hanke; M Höher |
Related Documents
:
|
22112597 - Long-term exposure to combination antiretroviral therapy and risk of death from specifi... 9309397 - The columnar-lined esophagus. history, terminology, and clinical issues. 9511607 - The fluoride content of enamel as a diagnostic aid in fluorosis. 22313707 - Implementation of effective alcohol control strategies is needed at large sports and en... 9451477 - The needs of asians and pacific islanders living with hiv in new york city. 14685237 - A larval devonian lungfish. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Nuclear medicine communications Volume: 23 ISSN: 0143-3636 ISO Abbreviation: Nucl Med Commun Publication Date: 2002 Sep |
Date Detail:
|
Created Date: 2002-08-26 Completed Date: 2002-11-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 8201017 Medline TA: Nucl Med Commun Country: England |
Other Details:
|
Languages: eng Pagination: 843-5 Citation Subset: IM |
Affiliation:
|
Department of Nuclear Medicine, University of Ulm, Germany. joerg.kotzerke@mailbox.tu-dresden.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty
/
adverse effects Angioplasty, Transluminal, Percutaneous Coronary / methods* Animals Brachytherapy / methods* Coronary Restenosis / diagnosis, etiology, prevention & control*, radiotherapy* Humans Rabbits Radiation Dosage Radioisotopes / diagnostic use, therapeutic use* Rhenium / diagnostic use, therapeutic use* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Radioisotopes; 7440-15-5/Rhenium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interventional nuclear medicine in hepatocellular carcinoma and other tumours.
Next Document: Practical aspects of intra-arterial brachytherapy.